The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic β-Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm That the KCNJ11 E23K Variant Is Associated With Type 2 Diabetes
Open accessAbstract
The genes ABCC8 and KCNJ11, which encode the subunits sulfonylurea receptor 1 (SUR1) and inwardly rectifying potassium channel (Kir6.2) of the β-cell ATP-sensitive potassium (KATP) channel, control insulin secretion. Common polymorphisms in these genes (ABCC8 exon 16–3t/c, exon 18 T/C, KCNJ11 E23K) have been variably associated with type 2 diabetes, but no large (∼2,000 subjects) case-control studies have been performed. We evaluated the role of these three variants by studying 2,486 U.K. subjects: 854 with type 2 diabetes, 1,182 population control subjects, and 150 parent-offspring type 2 diabetic trios. The E23K allele was associated with diabetes in the case-control study (odds ratio [OR] 1.18 [95% CI 1.04–1.34], P = 0.01) but did not show familial association with diabetes. Neither the exon 16 nor the exon 18 ABCC8 variants were associated with diabetes (1.04 [0.91–1.18], P = 0.57; 0.93 [0.71–1.23], P = 0.63, respectively). Meta-analysis of all case-control data showed that the E23K allele was associated with type 2 diabetes (K allele OR 1.23 [1.12–1.36], P = 0.000015; KK genotype 1.65 [1.34–2.02], P = 0.000002); but the ABCC8 variants were not associated. Our results confirm that E23K increases risk of type 2 diabetes and show that large-scale association studies are important for the identification of diabetes susceptibility alleles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, different isoforms of the two subunits are expressed, depending on the tissue-specific expression of the KATP-channels: SUR1 and Kir6.2 are expressed in the pancreas and brain,296 Kir6.2 and SUR2A are expressed in the heart and skeletal muscle,297 while SUR2B is expressed in the brain and smooth muscle,298 and Kir6.1 and SUR2B are expressed in vascular smooth muscle.299”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [296]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Defects in ion channels underlie many major disorders in humans, also known as channelopathies, including neuronal disorders76, diabetes77 and heart failure78.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Finally, a common variant in Kir6.2 (E23K) is associated with a slightly increased risk of T2DM (216, 586). While its effects on KATP channel activity (604, 605) and insulin secretion (696) are very small (585) and controversial (552), it is important to note that even a tiny increase in channel activity can lead to ND (705).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [216]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [3]
In the citing paper
“The other known T2D susceptibility variants were detected with effect sizes consistent with previous reports (2, 3).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
An efficient procedure for genotyping single nucleotide polymorphisms
Ye, S. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.17.e88 · Cited by 1,013
Handbook of Human Genetic Linkage.
Edwards, A. W. F., Terwilliger, J. D., & Ott, J. (1996) · Biometrics · doi:10.2307/2533082 · Cited by 873
Association and Stoichiometry of KATP Channel Subunits
Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., & Bryan, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80321-9 · Cited by 692
A Generalization of the Transmission/Disequilibrium Test for Uncertain-Haplotype Transmission
Clayton, D. G. (1999) · The American Journal of Human Genetics · doi:10.1086/302577 · Cited by 634
Linkage disequilibrium and the mapping of complex human traits.
Weiss, K., & Clark, A. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02550-1 · Cited by 423
Keavney, B. D., McKenzie, C. A., Parish, S., Palmer, A., Clark, S. J., Youngman, L. D., Délepine, M., Lathrop, M. G., Peto, R., & Collins, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)82009-7 · Cited by 345
Wiltshire, S., Hattersley, A. T., Hitman, G. A., Walker, M., Lévy, J., Sampson, M., O’Rahilly, S., Frayling, T. M., Bell, J. I., Lathrop, M. G., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323249 · Cited by 303
Self-citationHani, E. H., Boutin, P., Durand, E., Inoue, H., Permutt, M. A., Velho, G., & Froguel, P. (1998) · Diabetologia · doi:10.1007/s001250051098 · Cited by 268
Cited by
Sorted by citations
Items 401–500 of 753
He, B., Li, X., & Zhou, Z. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13114 · Cited by 21
Laramie, J. M., Wilk, J. B., Williamson, S. L., Nagle, M. W., Latourelle, J. C., Tobin, J. E., Province, M. A., Borecki, I. B., & Myers, R. H. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-46 · Cited by 20
Light, P. E. (2010) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s6969 · Cited by 22
Liu, N., Wu, H., Li, Y.-L., YANG, Z. K., Tao, X., Du, Y., Wang, X., Lü, B., Zhang, Z., Hu, R., et al. (2015) · European journal of medical research · doi:10.1186/s40001-014-0075-3 · Cited by 20
Čejková, P., Novota, P., Černá, M., Kološtová, K., Nováková, D., Kučera, P., Novak, J., Anděl, M., Weber, P., & Z̆dárský, E. (2008) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2008.00749.x · Cited by 17
Bennett, A. J., Sovio, U., Ruokonen, A., Martikainen, H. K., Pouta, A. M., Taponen, S., Hartikainen, A. L., Franks, P. W., Peltonen, L., Elliott, P., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1737-z · Cited by 20
Self-citationDorothy Hodgkin Lecture 2010^. From hype to hope? A journey through the genetics of Type 2 diabetes
McCarthy, M. I. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03194.x · Cited by 20
Self-citationAssociation between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation
Parvizi, Z., Azarpira, N., Kohan, L., Darai, M., Kazemi, K., & Parvizi, M. M. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3483-0 · Cited by 19
Amini, S., Javanmardi, M., Mokarizadeh, A., Maroofi, F., Jalali, C., Azadi, N. A., Mohammadi, H., & Abdi, M. (2015) · QJM · doi:10.1093/qjmed/hcv149 · Cited by 19
Diabetes: Symptoms, Cause and Potential Natural Therapeutic Methods
Awasthi, A., Parween, N., Singh, V. K., Anwar, A., Prasad, B., & Kumar, J. (2016) · Advances in Diabetes and Metabolism · doi:10.13189/adm.2016.040102 · Cited by 19
Khatami, F., Mohajeri‐Tehrani, M. R., & Tavangar, S. M. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190228102212 · Cited by 19
IGF2BP2 Genetic Variation and Type 2 Diabetes: A Global Meta-Analysis
Zhao, Y., Ma, Y., Fang, Y., Liu, L., Wu, S., Fu, D., & Wang, X. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1400 · Cited by 19
Tangjittipokin, W., CHONGJAREAN, N., Plengvidhya, N., Homsanit, M., & Yenchitsomanus, P. (2012) · Journal of Genetics · doi:10.1007/s12041-012-0176-0 · Cited by 19
Yao, H., Wang, Z., Wang, T., Ma, Y., Su, Y., Ma, Q., Wang, L., & Zhu, J. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120911797 · Cited by 19
Pharmacogenetics of Major Depression
Lekman, M., Paddock, S., & McMahon, F. J. (2008) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256297 · Cited by 20
Ríos, R., Lupiañez, C. B., Campa, D., Martino, A., Martínez‐López, J., Martínez‐Bueno, M., Várkonyi, J., García‐Sánz, R., Jamroziak, K., Dumontet, C., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0029 · Cited by 18
Tanahashi, T., Shinohara, K., Keshavarz, P., Yamaguchi, Y., Miyawaki, K., Kunika, K., Moritani, M., Nakamura, N., Yoshikawa, T., Shiota, H., et al. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02315.x · Cited by 18
Sachse, G., Haythorne, E., Hill, T., Proks, P., Joynson, R., Terrón-Expósito, R., Bentley, L., Tucker, S. J., Cox, R., & Ashcroft, F. M. (2021) · Diabetes · doi:10.2337/db20-0691 · Cited by 18
Sayed, S., & Nabi, A. H. M. N. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_518 · Cited by 18
Johansen, A., Jensen, D. P., Bergholdt, R., Mortensen, H. B., Pociot, F., Nerup, J., Hansen, T. F., Pedersen, O. B., & The Danish Society of Childhood Diabetes (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00471.x · Cited by 18
Gestational diabetes mellitus screening based on the gene chip technique
Liang, Z., Dong, M., Cheng, Q., & Chen, D. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.04.001 · Cited by 18
Nair, A. K., Sutherland, J. R., Traurig, M. T., Piaggi, P., Chen, P., Kobes, S., Hanson, R. L., Bogardus, C., & Baier, L. J. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-017-0062-6 · Cited by 17
Zhang, M., Zhou, J. J., Cui, W., Li, Y., Yang, P., Chen, X., Sheng, C., Li, H., & Qu, S. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12253 · Cited by 17
Ezenwaka, C. E., Kalloo, R., Uhlig, M., Schwenk, R. W., & Eckel, J. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06117 · Cited by 16
Webster, R. J., Warrington, N. M., Beilby, J. P., Frayling, T. M., & Palmer, L. J. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-140 · Cited by 18
Self-citationBarber, T. M., Bennett, A. J., Gloyn, A. L., Groves, C. J., Sovio, U., Ruokonen, A., Martikainen, H. K., Pouta, A. M., Taponen, S., Weedon, M. N., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201802 · Cited by 17
Self-citationPharmacogenetics: potential role in the treatment of diabetes and obesity
Vella, A., & Camilleri, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1109 · Cited by 17
Zhuang, L., Zhao, Y., Zhao, W., Li, M., Yu, M., Lü, M., Zhang, R., Ge, X., Zheng, T., Li, C., et al. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2373-7 · Cited by 19
A Genome-Wide Association Study Primer for Clinicians
Wang, T., & Wang, H. (2009) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60265-5 · Cited by 17
Genomics and Successful Aging: Grounds for Renewed Optimism?
Pilling, L. C., Harries, L. W., Powell, J. E., Llewellyn, D. J., Ferrucci, L., & Melzer, D. R. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls091 · Cited by 17
Not the second fiddle: α cell development, identity, and function in health and diabetes
Brooks, E. P., & Sussel, L. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0297 · Cited by 18
Takeuchi, M., Okamoto, K., Takagi, T., & Ishii, H. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00040.x · Cited by 15
Jiang, Y., Chuang, L., Pei, D., Lee, Y., Wei, J.-N., Sung, F., & Chang, T. (2014) · International Journal of Endocrinology · doi:10.1155/2014/983016 · Cited by 16
Genetic basis of β‐cell dysfunction in man
Groop, L., & Lyssenko, V. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01117.x · Cited by 17
Lu, Q. L., Wei, C., Ye, C., Li, M., & Elston, R. C. (2012) · Genetic Epidemiology · doi:10.1002/gepi.21651 · Cited by 16
Mining the Genome for Therapeutic Targets
Florez, J. C. (2017) · Diabetes · doi:10.2337/dbi16-0069 · Cited by 17
Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy
Broadgate, S., Kiire, C. A., Halford, S., & Chong, V. N. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13678 · Cited by 15
Self-citationThe Pharmacology of ATP-Sensitive K+ Channels (KATP)
Li, Y., Aziz, Q. H., & Tinker, A. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_466 · Cited by 18
Genetic Determinants of Type 2 Diabetes in Asians
Qi, Q., Wang, X., Strizich, G., & Wang, T. (2015) · International Journal of Diabetology & Vascular Disease Research · doi:10.19070/2328-353x-si01001 · Cited by 19
Iklé, J. M., & Gloyn, A. L. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0067 · Cited by 14
Self-citationα-cell electrophysiology and the regulation of glucagon secretion
Gao, R., Acreman, S., Ma, J., Abdulkader, F., Wendt, A., & Zhang, Q. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0295 · Cited by 23
Chen, Z., Pereira, M. A., Seielstad, M. T., Koh, W., Tai, E. S., Teo, Y.-Y., Liu, J., Hsu, C., Wang, R., Odegaard, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087762 · Cited by 15
Du, B., Liu, S., Cui, C., Wang, S., & Cui, W. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12042 · Cited by 15
Lu, J., Luo, Y., Wang, J., Hu, C., Zhang, R., Wang, C., & Jia, W. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12546 · Cited by 14
Nutrigenetics: Bridging Two Worlds to Understand Type 2 Diabetes
Harrington, J. M., & Phillips, C. M. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0477-1 · Cited by 15
Lasram, K., Halim, N. B., Hsouna, S., Kéfi, R., Arfa, I., Ghazouani, W., Jamoussi, H., Benrahma, H., Kharrat, N., Rebaï, A., et al. (2014) · BioMed Research International · doi:10.1155/2014/265274 · Cited by 15
Freathy, R. M., Weedon, M. N., Shields, B. M., Hitman, G. A., Walker, M., McCarthy, M. I., Hattersley, A. T., & Frayling, T. M. (2006) · PubMed · doi:10.25405/ncl.34627461 · Cited by 15
Self-citationThe New Perspectives on Genetic Studies of Type 2 Diabetes and Thyroid Diseases
Xu, M., Bi, Y., Cui, B., Hong, J., Wang, W., & Ning, G. (2013) · Current Genomics · doi:10.2174/138920213804999138 · Cited by 14
Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis
Denton, J. S., & Jacobson, D. A. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.09.004 · Cited by 15
Pirie, F. J., Motala, A. A., Pegoraro, R. J., Paruk, I. M., Govender, T., & Rom, L. (2010) · Cited by 14
GENETIC FACTORS INVOLVED IN THE PATHOGENESIS OF TYPE 2 DIABETES
Guja, C., Gagniuc, P. A., & Ionescu-Tîrgovi, C. (2012) · Cited by 14
Webster, N. J., Searle, G. J., Lam, P. P. L., Huang, Y., Riedel, M. J., Harb, G., Gaisano, H. Y., Holt, A., & Light, P. E. (2008) · Endocrinology · doi:10.1210/en.2007-1138 · Cited by 14
Flechtner, I., Vaxillaire, M., Cavé, H., Scharfmann, R., Froguel, P., & Polak, M. (2007) · KARGER eBooks · doi:10.1159/000109636 · Cited by 14
Recent advances in the genetics of diabetes
Pearson, E. R. (2008) · Primary care diabetes · doi:10.1016/j.pcd.2007.12.005 · Cited by 14
Quantitative traits associated with the Type 2 diabetes susceptibility allele in Kir6.2
Weedon, M. N., Gloyn, A. L., Smith, G. D., Ben‐Shlomo, Y., Frayling, T. M., & Hattersley, A. T. (2003) · Diabetologia · doi:10.1007/s00125-003-1135-3 · Cited by 14
Self-citationFlorez, J. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1402 · Cited by 14
Sapin, E., Keedwell, E. C., & Frayling, T. M. (2015) · IEEE Computational Intelligence Magazine · doi:10.1109/mci.2015.2471236 · Cited by 14
Self-citationFletcher, P. A., Thompson, B., Liu, C., Bertram, R., Satin, L. S., & Sherman, A. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00030.2023 · Cited by 13
Zhang, Y.-X., Liu, Y., Dong, J., Wang, Y., Wang, J., Zhuang, G.-Q., Han, S.-J., Guo, Q.-Q., Luo, Y.-X., Zhang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056365 · Cited by 13
Owusu, D., Pan, Y., Xie, C., Harirforoosh, S., & Wang, K. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.015 · Cited by 13
Shalimova, A., Fadieienko, G. D., Kolesnikova, O. V., Isayeva, G., Zlatkina, V. V., Nemtsova, V. D., Prosolenko, K., Psarova, V., Kyrychenko, N., & Kochuieva, M. M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190314124049 · Cited by 13
Yi, Y., Dongmei, L., Phares, D. A., Weiss, E. P., Brandauer, J., & Hagberg, J. M. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2007.038893 · Cited by 13
Glucokinase (GCK) and other susceptibility genes for β-cell dysfunction: the candidate approach
Gloyn, A. L., Tribble, N. D., van de Bunt, M., Barrett, A., & Johnson, P. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360306 · Cited by 14
Self-citationPharmacogenetics for Type 2 Diabetes: Practical Considerations for Study Design
Vella, A. V. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300415 · Cited by 13
Sánchez‐Maldonado, J. M., Collado, R., Cabrera-Serrano, A. J., ter Horst, R., Gálvez-Montosa, F., Robles‐Fernandez, I., Arenas-Rodríguez, V., Cano-Gutiérrez, B., Bakker, O. B., Bravo-Fernández, M. I., et al. (2022) · Cancers · doi:10.3390/cancers14102376 · Cited by 11
Bridging the Gap Between Genetic Associations and Molecular Mechanisms for Type 2 Diabetes
Ng, H. J., & Gloyn, A. L. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0429-1 · Cited by 12
Self-citationFrom genotype to human β cell phenotype and beyond
Marchetti, P., Syed, F., Suleiman, M., Bugliani, M., & Marselli, L. (2012) · Islets · doi:10.4161/isl.22282 · Cited by 12
Polymorphism E23K (rs5219) in the KCNJ11 gene in Euro-Brazilian subjects with type 1 and 2 diabetes
de Souza, S. W., Alcazar, L. P., Arakaki, P. A., dos Santos-Weiss, I. C. R., Alberton, D., Picheth, G., & Rego, F. G. D. M. (2017) · Genetics and Molecular Research · doi:10.4238/gmr16029543 · Cited by 13
Cheung, C. Y. Y., Tso, A. W. K., Cheung, B. M. Y., Xu, A., Fong, C. H.-Y., Ong, K. L., Law, L. S., Wat, N. M. S., Janus, E. D., Sham, P. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028598 · Cited by 12
Mechanisms of Action of Medicines for Schizophrenia and Bipolar Illness: Status and Limitations
Scolnick, E. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.022 · Cited by 11
Genetic Architecture of Type 2 Diabetes
Prasad, R. B., & Groop, L. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch14 · Cited by 12
Benhima (1962) · Présence Africaine · doi:10.3917/presa.042.0147 · Cited by 13
Evolving to Personalized Medicine for Type 2 Diabetes
Reddy, S. S. K. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.07.001 · Cited by 12
Viji, D., Aswathi, P., Charmine, P. P., Husain, R. S. A., Ameen, S. N., Ahmed, S. S. S. J., & Veerabathiran, R. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.10.015 · Cited by 11
Shimajiri, Y., Yamana, A., Morita, S., Furuta, H., Furuta, M., & Sanke, T. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12070 · Cited by 11
Lang, V., Youssef, N., & Light, P. E. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0233-8 · Cited by 11
CHOP T/C and C/T haplotypes contribute to early‐onset type 2 diabetes in Italians
Gragnoli, C. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21553 · Cited by 11
Gloyn, A. L., Mackay, D., Weedon, M. N., McCarthy, M. I., Walker, M., Hitman, G. A., Knight, B., Owen, K. R., Hattersley, A. T., & Frayling, T. M. (2006) · Diabetes · doi:10.2337/db06-0216 · Cited by 11
Self-citationSquires, P. E., Churamani, D., Pararajasingam, R., Persaud, S. J., & Jones, P. M. (2005) · Pancreas · doi:10.1097/01.mpa.0000153614.55761.49 · Cited by 11
Early onset diabetes mellitus. Tip or iceberg?
Polychronakos, C. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00066.x · Cited by 11
Pharmacogenetics of oral antidiabetic treatment
Schroner, Z., Javorský, M., Kozárová, M., & Tkac, I. (2011) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657490 · Cited by 10
Association of FTO, KCNJ11, SLC30A8, and CDKN2B polymorphisms with type 2 diabetes mellitus
Nikitin, A. G., Potapov, V. A., Бровкин, А. Н., Лаврикова, Е. Ю., Ходырев, Д. С., Шамхалова, М. Ш., Андреевна, С. С., Суплотова, Л. А., Shestakova, M. V., Nosikov, V. V., et al. (2015) · Molecular Biology · doi:10.1134/s0026893315010112 · Cited by 10
Xu, M., Hu, H., Deng, D., Chen, M., Xu, Z., & Wang, Y. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12565 · Cited by 10
Bakhtiyari, A., Haghani, K., Bakhtiyari, S., Zaimy, M. A., Noori-Zadeh, A., Gheysarzadeh, A., Darabi, S., Seidkhani‐Nahal, A., Amraei, M., & Alipourfard, I. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200713091827 · Cited by 10
McCarthy, M. I. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.024 · Cited by 10
Self-citationGenetic influences on the association between fetal growth and susceptibility to type 2 diabetes
Shields, B. M., Freathy, R. M., & Hattersley, A. T. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000127 · Cited by 10
Self-citationGenetics: how the UKPDS contributed to determining the genetic landscape of Type 2 diabetes
Gloyn, A. L., & McCarthy, M. I. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02500.x · Cited by 10
Self-citationIdentifying Susceptibility Variants for Type 2 Diabetes
Zeggini, E., & McCarthy, M. I. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-389-9_16 · Cited by 10
Self-citationMcCarthy, M. I., Groop, P., & Hansen, T. F. (2005) · Diabetologia · doi:10.1007/s00125-005-1807-2 · Cited by 10
Self-citationIslet Function and Insulin Secretion
Jones, P. M., & Persaud, S. J. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch6 · Cited by 11
Pathogenesis of Type 2 Diabetes
Alsahli, M., & Gerich, J. E. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_7 · Cited by 8
Li, Y., Shen, K., Li, C., Yang, Y., Yang, M., Tao, W., He, S., Shi, L., & Yao, Y. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.48072 · Cited by 9
Association of ABCC8 and KCNJ11 gene variants with type 1 diabetes in south Indians
Reddy, S., Maddhuri, S., Nallari, P., Ananthapur, V., Kalyani, S., Krishna, M., Cherkuri, N., & Patibandala, S. (2021) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-021-00149-w · Cited by 10
Diniz, I. G., Noce, R. R. D., Pereira, A. P., da Silva, A. N. L. M., Sacuena, E. R. P., Lemes, R. B., Costa, G. D. L. C., de Araújo, G. S., Machado, J. L. P., Figueiredo, F. A. D. P. L., et al. (2022) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2021-0153 · Cited by 9
Type 2 diabetes genes – Present status and data from Norwegian studies
Hertel, J. K., Johansson, S., Midthjell, K., Nygard, O. K., Njølstad, P. R., & Molven, A. (2013) · Norsk Epidemiologi · doi:10.5324/nje.v23i1.1597 · Cited by 9
Elbein, S. C., Wang, X., Karim, M. A., Chu, W. S., & Silver, K. D. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-62 · Cited by 9
Adenosine triphosphate-sensitive potassium channels and cardiomyopathies (Review)
Liu, Z., CAI, H., Dang, Y., Qiu, C., & Wang, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4714 · Cited by 9
Surendran, S., Alsulami, S., Lankeshwara, R., Jayawardena, R., Wetthasinghe, K., Sarkar, S., Ellahi, B., Lovegrove, J. A., Anthony, D. J., & Vimaleswaran, K. S. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00749-8 · Cited by 9
Association of Kir6.2 and INS VNTR variants with glucose homeostasis in young obese
Fur, S. L., Fradin, D., Boileau, P., & Bougneres, P. F. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00090.2005 · Cited by 9
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Alsahli, M., & Gerich, J. E. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch10 · Cited by 11
Metadata
- Authors
- Gloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., McCarthy, M. I., Hattersley, A. T., & Frayling, T. M.
- Affiliations
- Centre for Molecular Genetics, Peninsula Medical School, Exeter, U.K.
- University of London (GB)
- Newcastle University (GB)
- The Diabetes Research Laboratories, Radcliffe Infirmary, University of Oxford, Oxford, U.K.
- Norfolk and Norwich University Hospital (GB)
- Imperial College London (GB)
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-02-01
- Volume
- 52
- Issue
- 2
- Pages
- 568-572
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2169174186
- Cited by
- 754
- References
- 27
- Citations by year
- 2026: 5 · 2025: 15 · 2024: 8 · 2023: 16 · 2022: 10 · 2021: 14 · 2020: 15 · 2019: 20 · 2018: 25 · 2017: 27 · 2016: 33 · 2015: 30 · 2014: 40 · 2013: 42 · 2012: 46
- FWCI
- 38.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, KCNJ11, ABCC8, Kir6.2, SUR1, ATP-sensitive potassium channels, genetic susceptibility, insulin secretion, pancreatic beta cells, parent-offspring trios, familial association
- MeSH terms
- Adult, Alleles, Diabetes Mellitus, Type 2, Exons, Female, Genotype, Humans, Islets of Langerhans, Male, Middle Aged, Receptors, Drug, Genetic Variation, Potassium Channels, Cohort Studies, ATP-Binding Cassette Transporters, Amino Acid Substitution, Potassium Channels, Inwardly Rectifying, Sulfonylurea Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
